Back

Predicting Short-term Effects on Blood Pressure, Kidney Function, and Serum Potassium with Heart failure Therapies and their Combinations

31 August 2026 (13:30 - 13:45)
Organised by: Logo
Congress Presentation Part of: Heart failure: the kidney is key Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Nelson Wang

The George Institute for Global Health, Sydney (Australia)

3 More presentations in this session

Presentation thumbnail
Kidney Function Decline, Heart Failure Hospitalization and the Effect of Empagliflozin in Heart Failure: An EMPEROR-Pooled Analysis
Professor N. Girerd (Nancy, FR)
Presentation thumbnail
Glomerular filtration rate slope as a surrogate endpoint for kidney disease progression in heart failure trials: An individual participant data meta-analysis
Doctor M. Vaduganathan (Boston, US)
Presentation thumbnail
Precision Phenotyping of Multi-Organ Fat Distribution Defines Distinct Cardiorenal-Metabolic and Heart Failure Risk Profiles
Doctor Y. Kway (Oxford, GB)

Access the full session

Session thumbnail
Heart failure: the kidney is key
Video

The Event

Event poster

ESC Congress 2026

31 August 2026 13:30 CET
You may be interested in
thumbnail
Webinar
Chronic kidney disease in heart failure patients: the role of cardio-renal clinics
15 November 2022
thumbnail
Congress Presentation
Pharmacological treatments in adults with chronic heart failure: a systematic review and component network meta-analysis
30 August 2025
thumbnail
Congress Presentation
Effects of hyperkalaemia and worsening renal function on pharmacotherapy in hospitalized patients with heart failure
20 May 2023
thumbnail
Webinar
MRAs in heart failure: what's old is new again
10 July 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources